Cabot Corporation $CBT Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC reduced its holdings in shares of Cabot Corporation (NYSE:CBT) by 75.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 9,079 shares of the specialty chemicals company’s stock after selling 27,222 shares during the quarter. SG Americas Securities LLC’s holdings in Cabot were worth $684,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CBT. Torren Management LLC purchased a new position in shares of Cabot in the 4th quarter valued at approximately $26,000. Rothschild Investment LLC increased its stake in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the last quarter. Global Retirement Partners LLC grew its holdings in shares of Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the last quarter. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

CBT traded down $0.40 during trading on Tuesday, hitting $87.20. The company’s stock had a trading volume of 5,654 shares, compared to its average volume of 478,357. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 16.52, a P/E/G ratio of 11.36 and a beta of 0.83. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The business’s fifty day simple moving average is $84.75 and its 200 day simple moving average is $76.65. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.47 by $0.14. The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts forecast that Cabot Corporation will post 6.34 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were paid a $0.4725 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is 35.73%.

Analyst Ratings Changes

CBT has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price target on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Mizuho increased their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Truist Financial initiated coverage on shares of Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 price target for the company. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Finally, UBS Group raised their target price on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $85.80.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.